ftInvstr
GPTHEALTH · Healthcare ₹158.9 +3.45% Mkt Cap ₹1298 Cr fair

GPTHEALTH

Healthcare Medical Care Facilities
₹158.9
+3.45% today · 30d -3.81%
as of 2026-09-04
Price · Daily Candles
“GPT Healthcare: DIIs boost holdings as Q4 profit climbs 13%, but FCF growth remains a concern.”
GPT Healthcare reported robust Q4 FY26 revenue growth of 24.62% YoY to ₹126 Cr and net profit growth of 13.0% YoY to ₹15 Cr. Despite this, the company's annual net profit for FY26 declined by 15.43% YoY to ₹42 Cr, and ML predictions flag weak FCF growth ranging from -40.14% to -50.0% for the next year. The stock currently trades at a TTM P/E of 27.01, significantly lower than the sector average.
BULL CASE
+Q4 FY26 revenue shot up by 24.62% YoY to ₹126 Cr, with net profit increasing by 13.0% YoY to ₹15 Cr.
+DIIs increased their stake by 0.63% QoQ to 6.83% in Q4 FY26.
+The trailing P/E of 27.01 is substantially lower than most peers like Apollo Hospitals (82.13) and Max Healthcare (67.07).
+Profitability is high with a 8.94% profit margin and a strong business score for profitability (75).
BEAR CASE
Annual net profit for FY26 saw a significant decline of 15.43% YoY, bringing the total to ₹42 Cr.
ML predictions indicate weak FCF growth, with forecasts ranging from -40.14% to -50.0% for the next year.
Operating profit margin (OPM) saw a 2.09% decline YoY in Q4 FY26.
The stock is 24.49% off its 52-week high of ₹185.0.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹126 Cr
+17.83% YoY
NET PROFIT
₹13 Cr
+65.73% YoY
OPM
20.44%
+3.02pp YoY
EPS
₹1.55
PE 27.01
Intrinsic value · DCF ₹170.19 · Margin of safety +7.1% (fair) · FCF yield 3.03%
◇ Sector Position
GPT Healthcare's TTM P/E of 27.01 is significantly lower than sector leaders like Apollo Hospitals (82.13) and Max Healthcare (67.07), but its ROCE is not provided to complete the peer performance picture.
PEERPEROCE %
GPTHEALTH27.01
APOLLOHOSP82.1320.26
MAXHEALTH67.0714.44
FORTIS94.2613.4
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
66
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation REASONABLE 60
Growth MUTED 45
Profitability HIGH 75
Technicals NEUTRAL 62
Risk LOW 80
Key Stats
TTM PE
27.01
P/B
4.51
52W HIGH
₹175.0
OFF HIGH
-9.2%
DIV YIELD
2.15%
MKT CAP
₹1298 Cr
◉ Active Signals
MACDNeutral0.488
RSI(14)Neutral57.92
Street Consensus
1 analyst
₹136.0
mean target
Low ₹136.0Now ₹158.9High ₹136.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold GPTHEALTH and at what entry.

Sign up freeSign in